Status:

COMPLETED

Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely Choledocholithiasis

Lead Sponsor:

University of California, San Francisco

Conditions:

Choleclithiasis

Common Bile Duct Stones

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Objective: We compared outcome parameters for good-risk patients with classic signs, symptoms, laboratory and abdominal imaging features of cholecystolithiasis and choledocholithiasis randomized to ei...

Detailed Description

Objective: We compared outcome parameters for good-risk patients with classic signs, symptoms, laboratory and abdominal imaging features of cholecystolithiasis and choledocholithiasis randomized to ei...

Eligibility Criteria

Inclusion

  • Age \> 18 years
  • Classic biliary-type pain
  • Ultrasonographic demonstration of cholecystolithiasis
  • Platelet count \> 100,000 per mm³ and prothrombin time \< 3 seconds of control
  • American Society of Anesthesiology (ASA) risk grade I or II:
  • Common bile duct diameter greater than 6 mm by ultrasound or computed tomography (CT) scan
  • Intrahepatic duct dilation as determined by ultrasound or CT scan Serum bilirubin greater than 2mg/dl, alkaline phosphatase and/or lipase more than 1.5 times upper limit of normal within 48 hours of intended first pro

Exclusion

  • History of bleeding disorders, platelet count \<100,000 per mm³ and/or prothrombin time \>3 seconds over control
  • Uremia as evidenced by a creatinine \> 3 mg/dl and/or blood urea nitrogen \> 50 mg/dl
  • Ultrasonography or CT evidence of cirrhosis, intrahepatic gallbladder, liver mass or abscess, or periampullary neoplasm
  • Insulin-dependent diabetes mellitus
  • Multiple prior laparotomies
  • Morbid obesity
  • Clinical, radiologic and/or biochemical evidence of cirrhosis or portal vein thrombosis
  • Pregnancy

Key Trial Info

Start Date :

January 1 1997

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2007

Estimated Enrollment :

122 Patients enrolled

Trial Details

Trial ID

NCT00807729

Start Date

January 1 1997

End Date

November 1 2007

Last Update

September 3 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

San Francisco General Hospital

San Francisco, California, United States, 94110